Hisamitsu Pharmaceutical Co's market cap is currently $2.28B. The company's EPS TTM is $1.386; its P/E ratio is 20.60; and it has a dividend yield of 2.04%. Hisamitsu Pharmaceutical Co is scheduled to report earnings on April 10, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Income Statement
Total Revenue	¥ 141.71B	¥ 128.33B	¥ 120.19B	¥ 114.51B	¥ 140.99B
Gross Profit	¥ 78.97B	¥ 72.70B	¥ 70.07B	¥ 69.17B	¥ 87.60B
Operating Income	¥ 13.17B	¥ 11.60B	¥ 9.34B	¥ 10.67B	¥ 22.73B
EBITDA	¥ 24.37B	¥ 16.55B	¥ 13.66B	¥ 14.75B	¥ 26.98B
Net Income	¥ 13.97B	¥ 11.74B	¥ 9.66B	¥ 9.25B	¥ 18.69B
Balance Sheet
Cash & Short-Term Investments	¥ 125.32B	¥ 136.87B	¥ 142.43B	¥ 136.00B	¥ 141.93B
Total Assets	¥ 328.78B	¥ 313.92B	¥ 302.86B	¥ 299.86B	¥ 307.40B
Total Debt	¥ 2.10B	¥ 2.29B	¥ 2.46B	¥ 1.60B	¥ 1.77B
Net Debt	¥ -110.36B	¥ -119.86B	¥ -126.83B	¥ -112.65B	¥ -105.28B
Total Liabilities	¥ 61.70B	¥ 55.51B	¥ 47.98B	¥ 46.06B	¥ 56.66B
Stockholders' Equity	¥ 264.88B	¥ 256.36B	¥ 253.16B	¥ 252.29B	¥ 249.27B
Cash Flow
Free Cash Flow	¥ 5.15B	¥ 4.82B	¥ 15.01B	¥ 1.90B	¥ 23.67B
Operating Cash Flow	¥ 18.19B	¥ 12.73B	¥ 19.20B	¥ 5.29B	¥ 27.39B
Investing Cash Flow	¥ -2.51B	¥ -23.87B	¥ -13.06B	¥ 7.82B	¥ -17.23B
Financing Cash Flow	¥ -16.69B	¥ -14.69B	¥ -15.19B	¥ -7.19B	¥ -11.73B

Currency in JPY

Hisamitsu Pharmaceutical Co Earnings and Revenue History

Income Statement >

Hisamitsu Pharmaceutical Co Debt to Assets

Balance Sheet >

Hisamitsu Pharmaceutical Co Cash Flow

Cash Flow >

Hisamitsu Pharmaceutical Co Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing